- 1.
Coelho, D.; Suormala, T.; Stucki, M.; et al. Gene identification for the cblD defect of vitamin B12 metabolism. N. Engl. J. Med. 2008, 358, 1454–1464. https://doi.org/10.1056/NEJMoa072200.
- 2.
Gerrard, A.; Dawson, C. Homocystinuria diagnosis and management: It is not all classical. J. Clin. Pathol. 2022, 75, 744–750. https://doi.org/10.1136/jcp-2021-208029.
- 3.
Martinelli, D.; Deodato, F.; Dionisi-Vici, C. Cobalamin C defect: Natural history, pathophysiology, and treatment. J. Inherit. Metab. Dis. 2011, 34, 127–135. https://doi.org/10.1007/s10545-010-9161-z.
- 4.
Available online: https://www.dshs.texas.gov/sites/default/files/lab/PDF/NBS/Newborn-Screening-Laboratory-Brochure,-publication-14-14057.pdf (accessed on 14 April 2025).
- 5.
Leonard, J.V.; Morris, A.A. Inborn errors of metabolism around time of birth. Lancet 2000, 356, 583–587. https://doi.org/10.1016/s0140-6736(00)02591-5.
- 6.
Valayannopoulos, V.; Poll-The, B.T. Diagnostic work-up in acute conditions of inborn errors of metabolism and storage diseases. Handb. Clin. Neurol. 2013, 113, 1553–1562. https://doi.org/10.1016/B978-0-444-59565-2.00025-3.
- 7.
American College of Medical Genetics and Genomics. ACMG ACT Sheets and Algorithms; American College of Medical Genetics and Genomics: Bethesda, MD, USA, 2001.
- 8.
Baumgartner, M.R.; Hörster, F.; Dionisi-Vici, C.; et al. Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia. Orphanet J. Rare Dis. 2014, 9, 130. https://doi.org/10.1186/s13023-014-0130-8.
- 9.
Kluijtmans, L.A.; Boers, G.H.; Stevens, E.M.; et al. Defective cystathionine beta-synthase regulation by S-adenosylmethionine in a partially pyridoxine responsive homocystinuria patient. J. Clin. Investig. 1996, 98, 285–289. https://doi.org/10.1172/jci118791.
- 10.
Sacharow, S.J.; Picker, J.D.; Levy, H.L. Homocystinuria Caused by Cystathionine Beta-Synthase Deficiency. In GeneReviews(R); University of Washington: Seattle, WA, USA, 1993.
- 11.
Weisfeld-Adams, J.D.; Morrissey, M.A.; Kirmse, B.M.; et al. Newborn screening and early biochemical follow-up in combined methylmalonic aciduria and homocystinuria, cblC type, and utility of methionine as a secondary screening analyte. Mol. Genet. Metab. 2010, 99, 116–123. https://doi.org/10.1016/j.ymgme.2009.09.008.
- 12.
Wu, S.N.; E, H.S.; Yu, Y.; et al. Variable phenotypes and outcomes associated with the MMACHC c.482G > A mutation: Follow-up in a large CblC disease cohort. World J. Pediatr. 2024, 20, 848–858. https://doi.org/10.1007/s12519-023-00770-2.